Literature DB >> 7421418

Lipoprotein lipid and protein synthesis in experimental nephrosis and plasmapheresis: II. Perfused rat liver.

T Brenner, E Shafrir.   

Abstract

Livers from rats with experimental hypoproteinemia induced by aminonucleoside-nephrosis or plasmapheresis were perfused with a [14C]-labeled amino acid mixture at physiological concentration. Compared to control rats, a significantly increased incorporation of the amino acid label was found in the apolipoproteins of the ultracentrifugally separated very low and high density lipoproteins (VLDL, HDL), and into albumin secreted into the perfusate. However, no increase in the amino acid-derived lable was detected in VLDL-or HDL-borne lipids in nephrosis or plasmapheresis. Perfusion with U-[14C]leucine as a lipogenesis precursor at < 10 times higher than physiological concentration resulted in 5-fold increase in the label incorporation into perfusate proteins in nephrosis but only in a slightly significant increase in perfusate lipids. In contrast, the incorporation of a preformed fatty acid, 9,10-[3H] oleate into VLDL and HDL lipids increased 3- to 4-fold in nephrosis. Both with leucine and oleate as precursors, the increments in the label appearing in perfusate proteins or lipids, respectively, were markedly greater than the increases in hepatic tissue proteins or lipids. The results indicate that amino acids are preferentially directed by the liver into the synthesis of circulating apolipoproteins and albumin in hypoproteinemia and do not seem to constitute an important precursor of the liporpotein lipids. The increased production of apolipoproteins is associated with an increased incorporation of preformed fatty acids into lipoprotein lipids in addition to the previously reported stimulation of hepatic de novo lipid synthesis from recursors other than amino acids.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7421418     DOI: 10.1007/bf02534013

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  24 in total

1.  ADIPOSE TISSUE IN EXPERIMENTAL NEPHROTIC SYNDROME.

Authors:  A GUTMAN; E SHAFRIR
Journal:  Am J Physiol       Date:  1963-10

2.  Plasma lipoprotein metabolism in perfused rat livers. I. Protein synthesis and entry into the plasma.

Authors:  D E HAFT; P S ROHEIM; A WHITE; H A EDER
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

3.  Studies on the synthesis and secretion of serum lipoproteins by rat liver slices.

Authors:  C M RADDING; D STEINBERG
Journal:  J Clin Invest       Date:  1960-10       Impact factor: 14.808

4.  Metabolic channeling in experimental nephrosis. V. Lipide metabolism in the early stages of the disease.

Authors:  J B MARSH; D L DRABKIN
Journal:  J Biol Chem       Date:  1958-02       Impact factor: 5.157

5.  Tissue distribution of C-14 after the intravenous injection of labeled free fatty acids and chylomicrons in nephrotic rats.

Authors:  C L MALMENDIER
Journal:  J Clin Invest       Date:  1962-01       Impact factor: 14.808

6.  Insulin and epinephrine sensitivity of isolated fat cells in experimental nephrosis.

Authors:  M Tashimo; I Matsuda
Journal:  Clin Chim Acta       Date:  1972-10       Impact factor: 3.786

7.  Albumin synthesis in perfused liver of normal and nephrotic rats.

Authors:  J Katz; G Bonorris; S Okuyama; A L Sellers
Journal:  Am J Physiol       Date:  1967-06

8.  The effects of actinomycin D on the siosynthesis of plasma lipoproteins.

Authors:  G R Faloona; B N Stewart; M Fried
Journal:  Biochemistry       Date:  1968-02       Impact factor: 3.162

9.  Lipoprotein lipid and protein synthesis in experimental nephrosis and plasmapheresis. I: Studies in rat in vivo.

Authors:  E Shafrir; T Brenner
Journal:  Lipids       Date:  1979-08       Impact factor: 1.880

10.  Electron microscopic and biochemical study of lipoprotein synthesis in the isolated perfused rat liver.

Authors:  A L Jones; N B Ruderman; M G Herrera
Journal:  J Lipid Res       Date:  1967-09       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.